{"protocolSection": {"identificationModule": {"nctId": "NCT02441101", "orgStudyIdInfo": {"id": "201409760"}, "organization": {"fullName": "University of Iowa", "class": "OTHER"}, "briefTitle": "Right Ventricular Septal Pacing in Patients With Right Bundle Branch Block and Heart Failure (The SPARK Trial)", "officialTitle": "Right Ventricular Septal Pacing in Patients With Right Bundle Branch Block and Heart Failure, a Pilot Clinical Trial (The SPARK Trial)", "acronym": "SPARK"}, "statusModule": {"statusVerifiedDate": "2024-05", "overallStatus": "TERMINATED", "whyStopped": "PI left the institution", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2016-02-01", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2020-02-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2020-02-11", "type": "ACTUAL"}, "studyFirstSubmitDate": "2015-05-06", "studyFirstSubmitQcDate": "2015-05-07", "studyFirstPostDateStruct": {"date": "2015-05-12", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2023-12-22", "resultsFirstSubmitQcDate": "2024-05-23", "resultsFirstPostDateStruct": {"date": "2024-06-18", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2024-05-23", "lastUpdatePostDateStruct": {"date": "2024-06-18", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR_INVESTIGATOR", "investigatorFullName": "Barry London", "investigatorTitle": "PI", "investigatorAffiliation": "University of Iowa"}, "leadSponsor": {"name": "Barry London", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "This clinical study has been designed to test whether a new pacing therapy would lead to improvement in heart function, symptoms and quality of life in a specific group of heart failure patients. This group has a unique electrical conduction problem (Right Bundle Branch Block) that did not respond well to the current available pacing therapy.", "detailedDescription": "This pilot clinical trial will be a randomized single blinded cross over trial. Each subject will undergo three study stages. Subject will be randomized initially to either of the two arms; experimental or placebo, and then will be followed up for 3 months for the first stage to assess outcomes. In the second stage, both arms transition to a two months, intervention free, wash out period. Finally, at the third stage both arms will cross over and subject will be followed up for an additional 3 months for outcomes assessment."}, "conditionsModule": {"conditions": ["Right Bundle-Branch Block", "Heart Failure"], "keywords": ["Cardiac Resynchronization therapy"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "SINGLE", "whoMasked": ["PARTICIPANT"]}}, "enrollmentInfo": {"count": 6, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "RV pacing optimization on/off", "type": "EXPERIMENTAL", "description": "RBBB pacing Arm 1 is RV pacing optimization on/off", "interventionNames": ["Device: RV DDD(R)-60 with AV optimization"]}, {"label": "RV pacing optimization off/on", "type": "PLACEBO_COMPARATOR", "description": "Standard demand pacing Arm 2 is RV pacing optimization off/on", "interventionNames": ["Device: RV DDD(R)-60"]}], "interventions": [{"type": "DEVICE", "name": "RV DDD(R)-60 with AV optimization", "description": "Device to be programmed for RV pacing with AV interval optimization at the bedside to produce QRS fusion with the native conduction down the native left bundle on surface EKG", "armGroupLabels": ["RV pacing optimization on/off"]}, {"type": "DEVICE", "name": "RV DDD(R)-60", "description": "AV settings programmed to minimize RV pacing - standard demand pacing programming.", "armGroupLabels": ["RV pacing optimization off/on"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change of LV Ejection Fraction Compared to Baseline", "description": "LV Ejection Fraction is defined as \\[(end diastolic volume minus end systolic volume) / (end diastolic volume\\] as measured by echocardiography.\n\nComparison of LV Ejection Fraction with RV pacing optimization on vs. RV pacing optimization off.\n\nArm 1 is RV pacing optimization on then off Arm 2 is RV pacing optimization off then on", "timeFrame": "Baseline to 3 months"}], "secondaryOutcomes": [{"measure": "Electrocardiographic: QRS Duration", "description": "Comparing baseline to intervention on Comparing intervention off to intervention off Expect statistically significant decrease with intervention on", "timeFrame": "Baseline to 3 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Cardiomyopathy; ischemic or non-ischemic on optimal medical therapy per current heart failure treatment guidelines for at least 3 months.\n* LVEF \\< 35% by trans-thoracic echocardiogram assessment\n* Prior implantation of pacemaker/defibrillator with at least an atrial and RV mid septal lead. Atrial lead can be waived if RV lead has atrial sensing capabilities\\*\n* Normal sinus rhythm at enrollment\n* RBBB with QRS duration \\>120 msec on 12 lead surface EKG.\n* PR interval \\<250 msec on 12 lead surface EKG\n\n  * Subjects with biventricular pacemaker/ICD will be eligible for enrollment if their LV lead pacing function has been turned off by the subject's primary cardiologist prior to study enrollment for at least 3 months (this could be due to lead malfunction or the decision to deactivate the LV pacing therapy for any reason per primary cardiologist discretion)\n\nExclusion Criteria:\n\n* Age younger than 18 years old\n* Pregnancy\n* Acute Myocardial infarction within 6 months of entry into the study\n* Inotrope dependent heart failure condition\n* Left ventricular assist device or heart transplantation\n* Any other known conditions other than heart failure that could limit survival to \\< 6 months.\n* Atrial fibrillation or flutter burden \\>10% of the time within the last 6 months\n* Atrioventricular node disease that requires ventricular pacemaker support \\>10% of the time", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Michael C Giudici, MD", "affiliation": "University of Iowa", "role": "STUDY_CHAIR"}, {"name": "Michael C Giudici, MD", "affiliation": "University of Iowa", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Shubba D Roy, MD", "affiliation": "University of Iowa", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Trisha Elliott, RTR", "affiliation": "University of Iowa", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "University of Iowa Hospitals and Clinics", "city": "Iowa City", "state": "Iowa", "zip": "52242", "country": "United States", "geoPoint": {"lat": 41.66113, "lon": -91.53017}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "RV Pacing Optimization on First, Then Off", "description": "Arm 1 is RV pacing optimization on first, then off\n\nAfter baseline measurements, RV DDD(R)-60 with AV optimization (Device is programmed for RV pacing with AV interval optimization at the bedside to produce QRS fusion with the native conduction down the native left bundle on surface EKG) is turned on for 3 months. After the outcome measurements, RV DDD(R)-60 with AV optimization is turned off for 3 months and final outcome measurements are performed. This is a crossover study."}, {"id": "FG001", "title": "RV Pacing Optimization Off First, Then on", "description": "Arm 2 is RV pacing optimization off first then on\n\nAfter baseline measurements, RV DDD(R)-60 with AV optimization (Device is programmed for RV pacing with AV interval optimization at the bedside to produce QRS fusion with the native conduction down the native left bundle on surface EKG) is turned off for 3 months. After the outcome measurements, RV DDD(R)-60 with AV optimization is turned on for 3 months and final outcome measurements are performed. This is a crossover study."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "2"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "2"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "0"}]}], "dropWithdraws": [{"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "PI relocated and study terminated", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "RV Pacing Optimization on First, Then Off", "description": "RV Pacing Optimization on first, then Off\n\nRV DDD(R)-60 with AV optimization: Device to be programmed for RV pacing with AV interval optimization at the bedside to produce QRS fusion with the native conduction down the native left bundle on surface EKG"}, {"id": "BG001", "title": "RV Pacing Optimization Off First, Then on", "description": "RV Pacing Optimization off first, then on\n\nRV DDD(R)-60: AV settings programmed to minimize RV pacing - standard demand pacing programming."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "6"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "3"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "3"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "78", "spread": "9"}, {"groupId": "BG001", "value": "62", "spread": "15"}, {"groupId": "BG002", "value": "70", "spread": "14"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "6"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "6"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "6"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "6"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change of LV Ejection Fraction Compared to Baseline", "description": "LV Ejection Fraction is defined as \\[(end diastolic volume minus end systolic volume) / (end diastolic volume\\] as measured by echocardiography.\n\nComparison of LV Ejection Fraction with RV pacing optimization on vs. RV pacing optimization off.\n\nArm 1 is RV pacing optimization on then off Arm 2 is RV pacing optimization off then on", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percent", "timeFrame": "Baseline to 3 months", "groups": [{"id": "OG000", "title": "RV Pacing Optimization on", "description": "Arm 1 is RV pacing optimization on\n\nRV DDD(R)-60 with AV optimization: Device to be programmed for RV pacing with AV interval optimization at the bedside to produce QRS fusion with the native conduction down the native left bundle on surface EKG"}, {"id": "OG001", "title": "RV Pacing Optimization Off", "description": "Arm 2 is RV pacing optimization off\n\nRV DDD(R)-60: AV settings programmed to minimize RV pacing - standard demand pacing programming."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "3"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "4"}, {"groupId": "OG001", "value": "4", "spread": "7"}]}]}]}, {"type": "SECONDARY", "title": "Electrocardiographic: QRS Duration", "description": "Comparing baseline to intervention on Comparing intervention off to intervention off Expect statistically significant decrease with intervention on", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Milliseconds", "timeFrame": "Baseline to 3 months", "groups": [{"id": "OG000", "title": "RV Pacing Optimization on", "description": "RV Pacing Optimization on\n\nRV DDD(R)-60 with AV optimization: Device to be programmed for RV pacing with AV interval optimization at the bedside to produce QRS fusion with the native conduction down the native left bundle on surface EKG"}, {"id": "OG001", "title": "RV Pacing Optimization Off", "description": "RV Pacing Optimization off\n\nRV DDD(R)-60: AV settings programmed to minimize RV pacing - standard demand pacing programming."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "3"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-36", "spread": "22"}, {"groupId": "OG001", "value": "2", "spread": "9"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Adverse Events and Serious Adverse Events were collected during enrollment period, up to 6 months", "description": "Medical record review and directly from participants", "eventGroups": [{"id": "EG000", "title": "RV Pacing Optimization on", "description": "Arm 1 RV pacing optimization on\n\nRV DDD(R)-60 with AV optimization: Device to be programmed for RV pacing with AV interval optimization at the bedside to produce QRS fusion with the native conduction down the native left bundle on surface EKG", "deathsNumAffected": 0, "deathsNumAtRisk": 4, "seriousNumAffected": 0, "seriousNumAtRisk": 4, "otherNumAffected": 0, "otherNumAtRisk": 4}, {"id": "EG001", "title": "RV Pacing Optimization Off", "description": "Arm 2 is RV pacing optimization off\n\nRV DDD(R)-60: AV settings programmed to minimize RV pacing - standard demand pacing programming.", "deathsNumAffected": 0, "deathsNumAtRisk": 4, "seriousNumAffected": 0, "seriousNumAtRisk": 4, "otherNumAffected": 0, "otherNumAtRisk": 4}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Barry London", "organization": "University of Iowa", "email": "barry-london@uiowa.edu", "phone": "319-356-2750"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2014-12-24", "uploadDate": "2023-12-22T17:07", "filename": "Prot_000.pdf", "size": 256606}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2014-12-24", "uploadDate": "2023-12-22T17:06", "filename": "SAP_001.pdf", "size": 115420}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}, {"id": "D000002037", "term": "Bundle-Branch Block"}, {"id": "D000006327", "term": "Heart Block"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000001145", "term": "Arrhythmias, Cardiac"}, {"id": "D000075224", "term": "Cardiac Conduction System Disease"}, {"id": "D000010335", "term": "Pathologic Processes"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M5309", "name": "Bundle-Branch Block", "asFound": "Bundle Branch Block", "relevance": "HIGH"}, {"id": "M9415", "name": "Heart Block", "asFound": "Bundle Branch Block", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M4453", "name": "Arrhythmias, Cardiac", "relevance": "LOW"}, {"id": "M1472", "name": "Cardiac Conduction System Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}}, "hasResults": true}